Grants and Contracts Details
Description
Lung cancer is the leading killer of all cancers and Kentucky has the highest rate of incidence and mortality from
this dreaded disease. Although lung cancer is the most preventable cancer, those who do not choose to stop
smoking will likely become the population that most needs the best available treatment for lung cancer. It is
important to acknowledge that great strides have been made in treatment options that extend the lifespan of those
afflicted. However, five-year survival rates are very low. We propose that development of new therapeutics
targeted to specific molecules important in the biology of non-small cell lung cancer is as important focal point of
research at this time. As such, we've developed new methods to interrogate large sets of genetic data to identify
new molecules that may be important in lung cancer biology and thus, potential new 'druggable' targets. In this
proposal we will describe dissection of the function of one such molecule, Dusp4, which is a potential tumor
suppressor gene in non-small cell lung cancer.
Status | Finished |
---|---|
Effective start/end date | 9/1/07 → 12/31/09 |
Funding
- KY Lung Cancer Research Fund: $144,086.00
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.